Previous work demonstrated that the rabbit smooth muscle myosin heavy chain gene showed sequence divergence at the 25kDa/50kDa junction of the S1 subfragment when compared to chicken gizzard and chicken epithelial nonmusde myosin. RNase protection analysis with a probe spanning this region detected two partially protected fragments which were not present In RNA from vascular tissue and only found In RNA from visceral tissue. The polymerase chain reaction was used to amplify a 162bp product from primers spanning the putative region of divergence and DNA sequence analysis revealed a seven amlno acid Insertion not previously detected In other characterised cDNA clones. RNase protection analysis using the PCR product as probe showed that the Inserted sequence was expressed exclusively In RNA from visceral tissue. Similar RNA analysis showed that the visceral Isoform was not expressed In 20 day fetal rabbit smooth muscle tissues. These results Indicated that the new visceral isoform was expressed in a tissue-specific and developmentally regulated manner. Genomic DNA sequencing and mapping of the exon-lntron boundaries showed that the visceral Isoform was the product of cassette-type alternative splicing. The Inclusion of a visceral-specific sequence near the Mg-ATPase domain and at the 25kDa/50kDa junction suggests that the visceral Isoform may be important for myosin function in smooth muscle cells.
INTRODUCTION
Previous analysis of protein extracts from smooth muscle tissues (1) and cultured vascular smooth muscle cells (2, 3) revealed the presence of two major protein bands designated SMI (204kDa) and SM2 (200kDa) myosin heavy chain (MHC) based on electrophoretic mobility in SDS-PAGE gels. It was subsequently demonstrated that the SMI and SM2 isoforms of rabbit (4, 5) and rat smooth muscle MHC were the poducts of alternative splicing of a single gene (6) . The SM2 isoform differed from SMI by an inserted sequence of nine amino acids and an in-frame stop codon at the carboxyl terminus which resulted in a shorter myosin tail. The expression of SMI and SM2 isoforms in smooth muscle cells was verified using anti-peptide specific antibodies to the unique amino acid sequences predicted from the nucleotide sequence of the corresponding cDNA clones (5, 7) . Further work showed that expression of SMI and SM2 was tissue-specific (5, 6) , developmentally regulated (8) and altered by culture conditions (7) .
Characterisation of the full-length rabbit uterus cDNA encoding smooth muscle MHC showed that the primary structure was more similar to the nonmuscle MHC-A and MHC-B genes than MHCs from striated muscle (9) . In the SI globular head region, rabbit smooth muscle MHC showed approximately 90% identity to the chicken gizzard (10) and chicken epithelial non-muscle MHC-A (11) genes. However, at the junction of the 25kDa/50kDa proteolytic fragments located downstream of the putative MgATPase domain, the amino acid comparison revealed a completely divergent region of 13 amino acids after which the high degree of homology was restored (9) . These observations raised the possibility that additional isoforms of smooth muscle MHC may be expressed in smooth muscle cells. The fact that the region of divergence was close to the functionally important ATP binding site suggested that any isoforms in this region may be important in defining the contractile properties of smooth muscle cells.
In order to obtain indirect evidence for the existence of additional isoforms of smooth muscle MHC, we constructed a probe from the area of the SI head spanning the region of sequence divergence (9) . RNase protection analysis of RNA from adult rabbit smooth muscle tissues showed that in addition to the expected fully protected fragment, two partially protected fragments were also observed but only in RNA from visceral tissues. These results strongly supported the idea that the smooth muscle MHC molecule showed heterogeneity in the SI globular head. In the present report we show directly by RNA-PCR and genomic DNA sequencing that the rabbit smooth muscle MHC gene encodes a visceral isoform which is produced by cassette type alternative splicing. The visceral isoform encodes seven unique amino acids at the boundary of the 25kDa/50kDa junction. Expression of the visceral isoform is tissue-specific and developmentally regulated.
EXPERIMENTAL PROCEDURES RNA extraction and analysis
Total RNA was isolated from adult and 20 day fetal rabbit (New Zealand White) tissues by the guanidinium thiocyanate procedure (12) . The tissues studied included aorta, vena cava, uterus, small intestine, large intestine, stomach, bladder, brain, heart and lungs. RNA samples were analysed by the RNase protection method described previously (6) . The first labelled probe was a 528bp Pstl-PvuII restriction fragment derived from cDNA clone PBRUC1 encoding rabbit smooth muscle MHC (9) . This probe spanned the 25kDa/50kDa junction of the smooth muscle MHC molecule in the region suspected of showing sequence divergence. The Pstl-PvuII fragment was subcloned into pTZ18 (Pharmacia) and linearised with Hindm. The 162bp PCR product (see below) was subcloned into the Smal site of pBluescript SK (Stratagene) and the plasmid linearised with EcoRI.
RNA-PCR
Total RNA from adult rabbit stomach was used for RNA-PCR. Twenty micrograms of total RNA was used tor first strand cDNA synthesis in a mixture containing 1 x Taq polymerase buffer (Promega), lmM dNTPs, 40 Units RNasin (Promega), 100 pmoles downstream primer and 200 Units Superscript (Gibco-BRL). The downstream primer (19mer) derived from cDNA clone PBRUC1 had the sequence 5' CAAGACGGTCAAGAA-TGAC 3' (Oswel DNA Service). The RNA was reverse transcribed at 37 °C for 60 minutes and an aliqout taken for amplification The cDNA sample was amplified in a mixture containing 1 xPCR buffer (Promega), 100 pmoles downstream primer, 100 pmoles upstream primer and 0.5 Units Taq polymerase (Promega). The upstream primer (19mer) also derived from PBRUC1 had the sequence 5'GTCATCCAGTA-CCTGGCCG 3'. The product was amplified using 25 cycles of denaturation (30 sec, 95°C), annealing (60 sec, 52°C) and extension (60 sec, 72°C). In addition to the expected amplification product of 140bp equivalent to PBRUC1 (9), a second product of approximately 160bp was also observed following acrylamide gel analysis of the PCR mixture. The DNA was reamplified by a further 25 cycles and the product checked by Southern blotting. The 160bp DNA fragment was then electroeluted from acrylamide, purified by phenol extraction and the ends filled in using Klenow fragment (Gibco-BRL). An aliquot of the blunt ended DNA was then subcloned into the Smal site of pBluescript SK.
DNA sequencing
Plasmids containing the 160bp amplified DNA insert were sequenced in both directions using Sequenase 2.0 (United States Biochemicals). Southern blotting using the PCR product as probe was used to locate the corresponding region of the gene for genomic DNA sequencing. Mapping of the exon-intron boundaries was verified by a) sequencing from the ends of genomic DNA subclones derived from the original genomic clone Xl-3 (9), b) 5' end-labelling the PCR primers with T4 polynucleotide kinase (Gibco-BRL) in order to sequence in opposite orientations across the exon-intron boundaries and c) using consensus sequences for the donor (GTA...) and acceptor (...CAG) splice sites of introns (13) .
cDNA library screening
A rabbit uterus cDNA library (9) constructed in XZAP (Stratagene) was screened with a 265bp EcoRI-PstI restriction fragment from the 5' end of cDNA clone PBRUC1 (9) . This 265bp sequence is common to both SMI and SM2 type MHC isoforms. Plasmid DNA sequencing from the 5' end of cDNA clones longer than 6.0kb was used to identify clones which may contain putative inserted sequences at the 25kDa/50kDa junction.
RESULTS
Evidence for sequence heterogeneity at the smooth muscle MHC 25kDa/50kDa junction RNase protection analysis using a probe spanning the 25kDa/50kDa junction was used to search for smoodi muscle myosin heterogeneity in the SI subfragment. As expected, the probe detected a fully protected fragment of approximately 53Obp, equivalent to the isoform encoded by cDNA clone PBRUC1 (Fig. 1 ). This isoform (corresponding to SMI MHC) was expressed in all adult smooth muscle tissues studied and was highly tissue-specific. The same probe, however, detected the presence of two partially protected fragments of approximately 400bp and 130bp which were only present in visceral type smooth muscle tissues (Fig. 1) . Longer film exposure failed to reveal the presence of these fragments in RNA from aorta and vena cava samples. The sizes of the partially protected fragments appeared to match with the length of the probe used and the region of divergence at the 25kDa/50kDa junction.
A unique isoform of smooth muscle MHC is expressed in visceral smooth muscle cells PCR was used to amplify DNA encoding the putative visceral isoform from adult rabbit stomach RNA. Southern blotting was used to identify positive clones which were then sequenced to provide direct evidence for the existence of the new isoform. The 162bp DNA sequence in Figure 2 (a) designated PBVISPCR2 was that derived from cloning the amplified DNA. The bracket shows the location of the seven amino acid insertion which is unique to the visceral isoform. The position of the isoform sequence was then mapped to its location in the previously reported genomic clone Xl-3 (9) by Southern blotting. Genomic DNA sequencing confirmed that the sequence was genuine (Fig. 2b) . The DNA sequence in Fig. 2b shows the position of To check expression of the visceral isoform, the PCR product was used as a probe in RNase protection analysis of RNA from smooth muscle tissues. The results in Fig. 3 confirm that the isoform is only expressed in visceral smooth muscle tissues. The probe fully protects a fragment of r62bp which is only present in visceral smooth muscle. Expression of the isoform appears to be strongest in RNA from large intestine and bladder. No expression was detected in aorta, vena cava and other rabbit tissues. Since the probe in Fig. 3 contains the exon-specific sequence for the visceral form, it can be used to reliably determine the ratio of visceral:vascular mRNAs in smooth muscle tissues. As expected, the probe partially protects two fragments of 63bp and 78bp corresponding to the vascular isoform (PBRUC1) which, although it is detected in all smooth muscle tissues, is only weakly expressed in visceral tissues. The uterus appears to express similar amounts of both isoforms.
To determine whether the visceral-specific exon was incorporated into an MHC molecule associated with either the SMI or SM2 type MHC isoforms, a cDNA library was screened to isolate cDNA clones encoding the visceral isoform. Thirteen cDNA clones greater than 6.0 kb in length were isolated and shown by DNA sequencing to begin further 5' upstream of the 25kDa/50kDa junction (data not shown). However, Southern blotting using an SM2 isoform-specific 5' end-labelled primer as probe (6) failed to detect the presence of the SM2 specific sequence and indicated that all the new cDNA clones were of the SMI type. Furthermore, none of the new SMI type cDNA clones hybridized to a 5' end-labelled primer encoding the visceral-specifc isoform. These results therefore suggested that the visceral-specific exon was not associated with the SMI type MHC. It was also apparent that both the SM2 and visceralspecific MHC isoforms were poorly represented in the rabbit uterus cDNA library, probably reflecting the fact that the ratio of SM1:SM2 in rabbit uterus is approximately 80:20. in 25-28 day old fetal rabbits (8) . The results of these studies put together confirm that expression of both vascular and visceral isoforms of smooth muscle MHC occurs during late fetal development in the rabbit. 
The visceral isoform of smooth muscle MHC is produced by alternative splicing
A combination of Southern blotting and DNA sequencing was used to locate the position of the visceral-specific exon in the corresponding genomic clone. The exon-intron organisation of the visceral isoform is shown in the Hindm partial restriction map in Fig. 4(a) . Exons designated number 5a and 6 represent the contiguous exons originally mapped to a 4.0kb region of genomic clone XI-3 after comparison with the cDNA clone PBRUC1 (9) . Exon 5b represents the visceral isoform mapped to a position between exons 5a and 6. This arrangement of exons suggests that the most likely mechanism of producing the visceral mRNA is by cassette type alternative splicing. The observation that the vascular form is expressed in all types of smooth muscle suggests that the mechanism Unking exon 5a to 6 is the prefered splicing pathway. The diagram in Fig. 4b shows the location of the visceralspecific exon with respect to its neighbouring exons which form the Mg-ATPase domain and 25kDa/5OkDa junction as part of the myosin SI subfragment. This arrangement of exons presumably arises as a result of the positive pressure to select this particular splicing pathway in visceral smooth muscle cells.
Expression of the visceral isoform is developmentalr egulated
To further study the factors regulating expression of the visceral isoform, RNase protection analysis was used to measure mRNA transcript levels for the visceral isoform in fetal tissue. The results in Fig. 5 show that when the visceral isoform was used as probe, expression could not be detected in smooth muscle tissues from 20 day old fetal rabbits. No expression could also be detected in 20 day fetal bladder tissue (data not shown). Previously it was shown that SMI and SM2 isoforms were developmentally regulated in vascular tissue, with the SMI isoform appearing first
DISCUSSION
The present results provide direct evidence for the existence of a visceral-specific isoform of MHC in rabbit smooth muscle cells. The visceral isoform contains an inserted sequence of seven amino acids located at the 25kDa/50kDa junction of the MHC molecule.
Expression of the visceral isoform is limited exclusively to visceral type smooth muscle tissue thus suggesting a link between expression of the isoform and MHC function in smooth muscle cells. Differences in the contractile properties between vascular and visceral smooth muscle cells are well known (eg 14) but little evidence is available to implicate differences in the MHC molecule as a possible mediator of some of these events. Although the significance of the inserted sequence for MHC function remains to be determined, the location of the small peptide sequence at the 25kDa/50kDa junction indicates that it may be important for folding of the MHC molecule and/or activity in the Mg-ATPase domain. The inserted sequence contains both a serine and tyrosine residue but it is unknown if the MHC molecule is phosphorylated in this region in vivo.
Although the present results suggest that the visceral-specific exon is most likely to be associated with the SM2 type MHC, the functional significance of this arrangement of exons remains to be determined. The production of a visceral-specific antipeptide antibody should permit a further investigation of its expression in smooth muscle cells. The finding that the smooth muscle MHC gene encodes multiple isoforms suggests that the proteins originally designated as SMI and SM2 MHC probably represent multiple forms which cannot be separated by one dimensional SDS-PAGE analysis. A similar but more complicated arrangement of alternatively spliced exons was reported for the Drosophila muscle MHC (15) , which showed that multiple isoforms could exist with only small differences in apparent molecular weight. Additional RNase protection analysis of the smooth muscle MHC gene using restriction fragments from PBRUC1 (9) showed that further isoforms might exist in other regions of the MHC molecule (Babij and Periasamy, unpublished) .
The demonstration of tissue-specific expression of an isoform of smooth muscle MHC provides a new mechanism of generating MHC isoform diversity in smooth muscle cells. Previously it was shown that me SMI and SM2 MHC isoforms were produced by alternative splicing of a single gene (6) but both isoforms were shown to be co-expressed in all smooth muscle cell types (4, 5, 6) . Other workers have proposed the existence of additional isoforms of MHC in smooth muscle cells (16, 17, 18) but no information is presently available to decide whether these putative forms are encoded by new genes or further alternative splicing mechanisms. The present results lend further support to the idea that alternative splicing is the major mechanism for generating MHC isoform diversity in smooth muscle cells. Furthermore the data suggests that an additional level of complexity characterises regulation of MHC expression in that a positive pressure is required for selection of the visceral splicing pathway (Fig. 4) . The observation that the vascular isoform is expressed in all smooth muscle cells suggests that it may represent a constitutive type of splicing pathway which has similarities to the default pattern shown by other muscle genes. The expression of the 21bp visceral-specifc exon only in visceral cells suggests that tissuespecific splicing factors may regulate its non-constitutive inclusion during RNA processing. The existence of putative tissue-specific splicing factors in muscle cells has gained support particularly through work on such genes as a-tropomyosin (19) and troponin T (20) which are known to produce tissue-specific and developmentally regulated isoforms.
Recently it was shown that two inserted sequences of 21 and 10 amino acids were present near the actin binding site and MgATPase domain respectively of the chicken nonmuscle MHC-B gene (21) . RNA analysis revealed that both inserted sequences were expressed in a tissue-dependent manner, with expression being restricted to nonmuscle cells of the nervous system. It was suggested that the isoforms were the likely result of alternative splicing although this awaits confirmation. If this is the case, then it suggests that remarkable similarites exist between the vertebrate smooth muscle (9) and nonmuscle MHC genes (11, 21) in terms of their ability to generate isoform diversity by the mechanism of alternative splicing. These results therefore support the idea that common evolutionary pathways were involved in the formation of this branch of the MHC gene family.
